[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371829-105":59,"doc-detail-371829-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","combined-mek-and-parp-inhibition-enhances-radiation-response-in-rectal-cancer","Combined MEK and PARP inhibition enhances radiation response in rectal cancer","","Rectal cancer is often diagnosed at a locally advanced stage and treated with neoadjuvant chemoradiation, but toxicity limits further intensification. To pursue alternative strategies, patient-derived rectal cancer organoids were used to model clinical radiosensitivity and screen 1,596 drug–radiation combinations. MEK inhibitors, by suppressing radiation-induced RAS–MAPK signaling and downregulating RAD51, strongly enhanced radiation response. Combined PARP and MEK inhibition further increased radiosensitivity in colorectal cancer organoids and cell lines and was validated in mouse xenograft models, supporting clinical evaluation of MEK–PARP with radiation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/combined-mek-and-parp-inhibition-enhances-radiation-response-in-rectal-cancer/371829/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/combined-mek-and-parp-inhibition-enhances-radiation-response-in-rectal-cancer/371829.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How were radiosensitivity models built for the study?","Question",{"text":113,"@type":114},"The study established patient-derived rectal cancer organoids that reflect clinical radiosensitivity, and used them to perform drug–radiation screening.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What did the drug-radiation screen identify as key radiation enhancers?",{"text":118,"@type":114},"Inhibitors targeting RAS-MAPK signaling, especially MEK inhibitors, were identified as potent irradiation enhancers.",{"name":120,"@type":111,"acceptedAnswer":121},"How does MEK inhibition enhance radiation response mechanistically?",{"text":122,"@type":114},"MEK inhibitors suppress radiation-induced RAS-MAPK signaling activation and selectively downregulate RAD51, a homologous recombination DNA repair protein.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},371829,1790617749,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398046744996,"Article  \nCombined MEK and PARP inhibition enhances radiation response in rectal cancer  \nGraphical abstract  \nHighlights  \n• Clinical radiosensitivity can be modeled with a rectal cancer organoid assay  \nAuthors  \nQiyun Xiao, Julian E. Riedesser, Theresa Mulholland, ..., Matthias P. Ebert, Tianzuo Zhan, Johannes Betge  \nCorrespondence  \ntianzuo.zhan@medma.uni-heidelberg.de (T.Z.),  \n[j.betge@dkfz.de](j.betge@dkfz.de) (J.B.)  \nIn brief  \nXiao et al. use patient-derived rectal cancer organoids to identify that MEK inhibitors enhance radiation sensitivity by downregulating the DNA damage response protein RAD51 . They find synergy with combined PARP inhibition indifferent preclinical models, thereby offering a promising regimen and potential future alternative to conventional chemoradiation in locally advanced rectal cancer.  \n• A drug-radiation screen identifies MEK inhibitors as potent irradiation enhancers  \n• MEK inhibitors downregulate the DNA damage response protein RAD51  \n• Combined MEK-PARP-radiation shows efficacy in organoid and xenograft models  \nXiao et al., 2025, Cell Reports Medicine 6, 102284  \nAugust 19, 2025 © 2025 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2025.102284](https://doi.org/10.1016/j.xcrm.2025.102284)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nCombined MEK and PARP inhibition enhances radiation response in rectal cancer  \nQiyun Xiao,1,2,16,17 Julian E. Riedesser,1,3,17 Theresa Mulholland,1,3,17 Zhenchong Li,1,3 Jonas Buchloh,1,3  \nPhilipp Albrecht,1,3 Xinchen Yang,1 Moying Li,1 Nachiyappan Venkatachalam,1 Olga Skabkina,1 Anna Klupsch,1  \nElla Eichhorn,1 Li Wang,1 Sebastian Belle,1 Nadine Schulte,1 Daniel Schmitz,4 Matthias F. Froelich,5 Kyrhatii Trikhirhisthit,3 Erica Valentini,6 Kim E. Boonekamp,6 Yvonne Petersen,1,3 Thilo Miersch,6 Elke Burgermeister,1 Carsten Herskind,7,14 Marlon R. Veldwijk,7,14 Christoph Brochhausen,8 Robert Ihnatko,9 Jeroen Krijgsveld,9 Ina Kurth,10,12 Yuxing Zhu,13 Yanni Ma,13 Ke Cao,13 Michael Boutros,6,11,12 Matthias P. Ebert,1,14,15,16 Tianzuo Zhan,1,14,15,16,17,*  \nand Johannes Betge1,3,12,14,15,18,17 ,*  \n1Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany  \n2Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, China  \n3Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Heidelberg, Germany  \n4Department of Gastroenterology and Infectiology, Helios Kliniken Schwerin, University Campus of Medical School Hamburg (MSH), Schwerin, Germany  \n5Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany  \n6Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany  \n7Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany  \n8Institute of Pathology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany  \n9Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany  \n10Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany  \n11Institute of Human Genetics, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany  \n12German Cancer Consortium (DKTK), Heidelberg, Germany  \n13Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, China  \n14DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany  \n15Man","cbCaieC3muSumhtH","https://ap.wps.com/l/cbCaieC3muSumhtH","pdf",11680442,28,"English","# Background\n# Organoid-based radiosensitivity modeling\n# Drug-radiation screening strategy\n# Mechanistic findings: RAS-MAPK signaling and RAD51\n# Combined MEK-PARP-radiation efficacy\n# Preclinical validation in xenograft models\n# Clinical implication","[{\"question\":\"How were radiosensitivity models built for the study?\",\"answer\":\"The study established patient-derived rectal cancer organoids that reflect clinical radiosensitivity, and used them to perform drug–radiation screening.\"},{\"question\":\"What did the drug-radiation screen identify as key radiation enhancers?\",\"answer\":\"Inhibitors targeting RAS-MAPK signaling, especially MEK inhibitors, were identified as potent irradiation enhancers.\"},{\"question\":\"How does MEK inhibition enhance radiation response mechanistically?\",\"answer\":\"MEK inhibitors suppress radiation-induced RAS-MAPK signaling activation and selectively downregulate RAD51, a homologous recombination DNA repair protein.\"}]","Combined MEK and PARP inhibition enhances radiation response in rectal cancer | PDF",1790192970,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29f3d772742651113f20ab01c57ba432.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d76995f44547af38450dbdee290f4171.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/120301d9f0999d9fbb515c1cbe71eace.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef6d7b13ebc32af61f4a33497539ab6e.webp",980,1272]